Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

14-3-3σ induces heat shock protein 70 expression in hepatocellular carcinoma.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • معلومة اضافية
    • المصدر:
      Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE
    • بيانات النشر:
      Original Publication: London : BioMed Central, [2001-
    • الموضوع:
    • نبذة مختصرة :
      Background: 14-3-3σ is implicated in promoting tumor development of various malignancies. However, the clinical relevance of 14-3-3σ in hepatocellular carcinoma (HCC) tumor progression and modulation and pathway elucidation remain unclear.
      Methods: We investigated 14-3-3σ expression in 109 HCC tissues by immunohistochemistry. Overexpression and knockdown experiments were performed by transfection with cDNA or siRNA. Protein expression and cell migration were determined by Western blot and Boyden chamber assay.
      Results: In this study, we found that 14-3-3σ is abundantly expressed in HCC tumors. Stable or transient overexpression of 14-3-3σ induces the expression of heat shock factor-1α (HSF-1α) and heat shock protein 70 (HSP70) in HCC cells. Moreover, expression of 14-3-3σ significantly correlates with HSF-1α/HSP70 in HCC tumors and both 14-3-3σ and HSP70 overexpression are associated with micro-vascular thrombi in HCC patients, suggesting that 14-3-3σ/HSP70 expression is potentially involved in cell migration/invasion. Results of an in vitro migration assay indicate that 14-3-3σ promotes cell migration and that 14-3-3σ-induced cell migration is impaired by siRNA knockdown of HSP70. Finally, 14-3-3σ-induced HSF-1α/HSP70 expression is abolished by the knockdown of β-catenin or activation of GSK-3β.
      Conclusions: Our findings indicate that 14-3-3σ participates in promoting HCC cell migration and tumor development via β-catenin/HSF-1α/HSP70 pathway regulation. Thus, 14-3-3σ alone or combined with HSP70 are potential prognostic biomarkers for HCC.
    • References:
      Oncogene. 2002 Nov 28;21(54):8293-301. (PMID: 12447692)
      J Biol Chem. 2002 Sep 13;277(37):33791-8. (PMID: 12097329)
      Histopathology. 2011 Apr;58(5):705-11. (PMID: 21401702)
      Cancer. 2001 Jul 1;92(1):136-45. (PMID: 11443619)
      Oncogene. 2000 Nov 2;19(46):5298-302. (PMID: 11077447)
      Semin Cell Dev Biol. 2011 Sep;22(7):673-80. (PMID: 21864699)
      Curr Med Chem. 2011;18(27):4250-64. (PMID: 21838681)
      Genes Chromosomes Cancer. 2011 Oct;50(10):830-6. (PMID: 21755566)
      Cancer. 2012 Apr 1;118(7):1782-94. (PMID: 22009757)
      Am J Pathol. 1999 Sep;155(3):703-10. (PMID: 10487827)
      J Hepatobiliary Pancreat Sci. 2011 Jul;18(4):544-50. (PMID: 21234611)
      Clin Cancer Res. 2008 Dec 1;14(23):7614-23. (PMID: 19047086)
      J Biol Chem. 2000 Jul 28;275(30):23106-12. (PMID: 10767298)
      Hepatology. 2012 Oct;56(4):1380-90. (PMID: 22706665)
      Oncogene. 2007 Feb 1;26(5):774-80. (PMID: 16964294)
      Am J Transl Res. 2009 Jun 08;1(4):326-40. (PMID: 19956445)
      Hepatology. 2002 Dec;36(6):1528-36. (PMID: 12447879)
      Clin Cancer Res. 2006 Oct 1;12(19):5746-54. (PMID: 17020980)
      BMC Cancer. 2011 Sep 20;11:397. (PMID: 21933426)
      Am J Pathol. 2012 Apr;180(4):1653-62. (PMID: 22310466)
      Int J Cancer. 2011 Nov 15;129(10):2445-53. (PMID: 21207417)
      Hum Pathol. 2009 Oct;40(10):1384-90. (PMID: 19454363)
      Proc Natl Acad Sci U S A. 2006 Nov 14;103(46):17237-42. (PMID: 17085597)
      J Gastroenterol. 2009;44 Suppl 19:108-11. (PMID: 19148803)
      Semin Cancer Biol. 2006 Jun;16(3):214-24. (PMID: 16698281)
      J Hepatol. 2009 Apr;50(4):746-54. (PMID: 19231003)
      Oncol Rep. 2007 Dec;18(6):1451-6. (PMID: 17982629)
      Carcinogenesis. 2004 Sep;25(9):1575-85. (PMID: 15073049)
      Cell Metab. 2011 Jul 6;14(1):91-103. (PMID: 21723507)
      Mol Cell Biol. 1998 Nov;18(11):6624-33. (PMID: 9774677)
      Mol Med Rep. 2010 Jul-Aug;3(4):589-96. (PMID: 21472284)
      Gut. 2012 Oct;61(10):1481-7. (PMID: 22287594)
      Nat Rev Cancer. 2003 Dec;3(12):931-43. (PMID: 14737123)
      Nature. 1999 Oct 7;401(6753):616-20. (PMID: 10524633)
      J Pathol. 2003 Oct;201(2):250-9. (PMID: 14517842)
      Hum Pathol. 2011 Jan;42(1):129-35. (PMID: 20870266)
      J Med Chem. 2010 Jun 24;53(12):4585-602. (PMID: 20334364)
      J Neurochem. 2000 Dec;75(6):2401-8. (PMID: 11080191)
      Am J Pathol. 2011 Dec;179(6):2698-708. (PMID: 21967815)
      Clin Cancer Res. 2005 May 1;11(9):3274-9. (PMID: 15867223)
      PLoS One. 2012;7(6):e40193. (PMID: 22768254)
      Hepatology. 2003 Jan;37(1):198-207. (PMID: 12500205)
      Trends Cell Biol. 1996 Jul;6(7):274-9. (PMID: 15157454)
      Hepatology. 2007 Mar;45(3):725-34. (PMID: 17326147)
      Clin Cancer Res. 2002 Feb;8(2):450-6. (PMID: 11839663)
      Br J Cancer. 1996 Nov;74(9):1445-51. (PMID: 8912543)
      Oncogene. 2002 Nov 28;21(54):8310-9. (PMID: 12447694)
    • الرقم المعرف:
      0 (14-3-3 Proteins)
      0 (Biomarkers, Tumor)
      0 (DNA-Binding Proteins)
      0 (HSP70 Heat-Shock Proteins)
      0 (Heat Shock Transcription Factors)
      0 (Transcription Factors)
      0 (beta Catenin)
      EC 3.1.- (Exoribonucleases)
      EC 3.1.- (SFN protein, human)
    • الموضوع:
      Date Created: 20140614 Date Completed: 20141209 Latest Revision: 20211021
    • الموضوع:
      20231215
    • الرقم المعرف:
      PMC4061114
    • الرقم المعرف:
      10.1186/1471-2407-14-425
    • الرقم المعرف:
      24923353